Sitosterolemia susceptibility gene (SSG) polypeptides
    1.
    发明授权
    Sitosterolemia susceptibility gene (SSG) polypeptides 失效
    肠易激综合征基因(SSG)多肽

    公开(公告)号:US07229816B2

    公开(公告)日:2007-06-12

    申请号:US11128026

    申请日:2005-05-11

    CPC分类号: C07K14/705

    摘要: The present invention provides polypeptides of a novel ABC family cholesterol transporter, SSG. The herein-disclosed sequences can be used for any of a number of purposes, including for the diagnosis and treatment of cholesterol-associated disorders, including sitosterolemia, and for the identification of molecules that associate with and/or modulate the activity of SSG.

    摘要翻译: 本发明提供新型ABC家族胆固醇转运蛋白SSG的多肽。 本文公开的序列可以用于许多目的中的任何一个,包括用于诊断和治疗胆固醇相关疾病,包括静脉麻醉,以及用于鉴定与SSG的活性相关和/或调节的分子。

    Screening methods using sitosterolemia susceptibility gene (SSG) polypeptides
    3.
    发明授权
    Screening methods using sitosterolemia susceptibility gene (SSG) polypeptides 失效
    使用静脉硬化易感基因(SSG)多肽的筛选方法

    公开(公告)号:US08257934B2

    公开(公告)日:2012-09-04

    申请号:US12705169

    申请日:2010-02-12

    CPC分类号: C07K14/705

    摘要: The present invention provides nucleic acids encoding a novel ABC family cholesterol transporter, SSG. The herein-disclosed sequences can be used for any of a number of purposes, including for the diagnosis and treatment of cholesterol-associated disorders, including sitosterolemia, and for the identification of molecules that associate with and/or modulate the activity of SSG.

    摘要翻译: 本发明提供编码新型ABC家族胆固醇转运蛋白SSG的核酸。 本文所公开的序列可用于许多目的中的任何一种,包括用于诊断和治疗胆固醇相关疾病,包括静脉麻醉,以及鉴定与SSG的活性相关和/或调节的分子。

    Sitosterolemia susceptibility gene (SSG): compositions and methods of use
    4.
    发明授权
    Sitosterolemia susceptibility gene (SSG): compositions and methods of use 失效
    肠易激综合征基因(SSG):组合物和使用方法

    公开(公告)号:US07662376B2

    公开(公告)日:2010-02-16

    申请号:US11647126

    申请日:2006-12-27

    CPC分类号: C07K14/705

    摘要: The present invention provides nucleic acids encoding a novel ABC family cholesterol transporter, SSG. The herein-disclosed sequences can be used for any of a number of purposes, including for the diagnosis and treatment of cholesterol-associated disorders, including sitosterolemia, and for the identification of molecules that associate with and/or modulate the activity of SSG.

    摘要翻译: 本发明提供编码新型ABC家族胆固醇转运蛋白SSG的核酸。 本文公开的序列可以用于许多目的中的任何一个,包括用于诊断和治疗胆固醇相关疾病,包括静脉麻醉,以及用于鉴定与SSG的活性相关和/或调节的分子。

    Sitosterolemia susceptibility gene (SSG): compositions and methods of use
    5.
    发明申请
    Sitosterolemia susceptibility gene (SSG): compositions and methods of use 失效
    肠易激综合征基因(SSG):组合物和使用方法

    公开(公告)号:US20080009608A1

    公开(公告)日:2008-01-10

    申请号:US11647126

    申请日:2006-12-27

    IPC分类号: C07K16/18

    CPC分类号: C07K14/705

    摘要: The present invention provides nucleic acids encoding a novel ABC family cholesterol transporter, SSG. The herein-disclosed sequences can be used for any of a number of purposes, including for the diagnosis and treatment of cholesterol-associated disorders, including sitosterolemia, and for the identification of molecules that associate with and/or modulate the activity of SSG.

    摘要翻译: 本发明提供编码新型ABC家族胆固醇转运蛋白SSG的核酸。 本文所公开的序列可用于许多目的中的任何一种,包括用于诊断和治疗胆固醇相关疾病,包括静脉麻醉,以及鉴定与SSG的活性相关和/或调节的分子。

    Sitosterolemia susceptibility gene (SSG): compositions and methods of use
    6.
    发明申请
    Sitosterolemia susceptibility gene (SSG): compositions and methods of use 失效
    肠易激综合征基因(SSG):组合物和使用方法

    公开(公告)号:US20050214850A1

    公开(公告)日:2005-09-29

    申请号:US11128026

    申请日:2005-05-11

    CPC分类号: C07K14/705

    摘要: The present invention provides polypeptides of a novel ABC family cholesterol transporter, SSG. The herein-disclosed sequences can be used for any of a number of purposes, including for the diagnosis and treatment of cholesterol-associated disorders, including sitosterolemia, and for the identification of molecules that associate with and/or modulate the activity of SSG.

    摘要翻译: 本发明提供新型ABC家族胆固醇转运蛋白SSG的多肽。 本文所公开的序列可用于许多目的中的任何一种,包括用于诊断和治疗胆固醇相关疾病,包括静脉麻醉,以及鉴定与SSG的活性相关和/或调节的分子。

    Nuclear hormone receptor drug screens
    10.
    发明授权
    Nuclear hormone receptor drug screens 有权
    核激素受体药物筛选

    公开(公告)号:US07101681B1

    公开(公告)日:2006-09-05

    申请号:US09163713

    申请日:1998-09-30

    IPC分类号: G01N33/53

    摘要: Methods for identifying modulators of nuclear hormone receptor function comprise the steps of (a) forming a mixture comprising a nuclear hormone receptor, a peptide sensor and a candidate agent, but not a natural coactivator protein of the receptor, wherein the sensor provides direct, in vitro binding to the receptor under assay conditions; (b) measuring an agent-biased binding of the sensor to the receptor; and (c) comparing the agent-biased binding with a corresponding unbiased binding of the sensor to the receptor. In particular embodiments, the sensor comprises an amphipathic alpha helix nuclear hormone interacting domain comprising a recited nuclear hormone transcriptional coactivator motif sequence, the sensor is present at sub-micromolar concentration, the binding reaction occurs in solution, the sensor comprises a fluorescent label and the measuring step comprises detecting fluorescence polarization of the label. Reagents include labeled sensor peptides and reaction mixtures consisting essentially of nuclear hormone receptor, a peptide and a candidate agent.

    摘要翻译: 用于鉴定核激素受体功能调节剂的方法包括以下步骤:(a)形成包含核激素受体,肽传感器和候选试剂但不是受体的天然共激活蛋白的混合物,其中所述传感器直接提供 在测定条件下与受体的体外结合; (b)测量传感器与受体的药剂偏置结合; 和(c)将代理偏好的结合与传感器与受体的相应的无偏见的结合进行比较。 在具体实施方案中,传感器包括包含所述核激素转录辅激动子序列的两亲性α螺旋核激素相互作用结构域,所述传感器以亚微摩尔浓度存在,所述结合反应发生在溶液中,所述传感器包含荧光标记和 测量步骤包括检测标签的荧光偏振。 试剂包括标记的传感器肽和基本上由核激素受体,肽和候选试剂组成的反应混合物。